These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9033639)

  • 1. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.
    Uyttenhove C; Godfraind C; Lethé B; Amar-Costesec A; Renauld JC; Gajewski TF; Duffour MT; Warnier G; Boon T; Van den Eynde BJ
    Int J Cancer; 1997 Jan; 70(3):349-56. PubMed ID: 9033639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection.
    Brändle D; Bilsborough J; Rülicke T; Uyttenhove C; Boon T; Van den Eynde BJ
    Eur J Immunol; 1998 Dec; 28(12):4010-9. PubMed ID: 9862337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815.
    Bilsborough J; Van Pel A; Uyttenhove C; Boon T; Van den Eynde BJ
    J Immunol; 1999 Mar; 162(6):3534-40. PubMed ID: 10092811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene.
    Colmenero P; Liljeström P; Jondal M
    Gene Ther; 1999 Oct; 6(10):1728-33. PubMed ID: 10516722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.
    Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE
    Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A.
    Rosato A; Zambon A; Milan G; Ciminale V; D'Agostino DM; Macino B; Zanovello P; Collavo D
    Hum Gene Ther; 1997 Aug; 8(12):1451-8. PubMed ID: 9287145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide.
    Grohmann U; Bianchi R; Fioretti MC; Fallarino F; Binaglia L; Uyttenhove C; Van Pel A; Boon T; Puccetti P
    Eur J Immunol; 1995 Oct; 25(10):2797-802. PubMed ID: 7589074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy.
    Rosato A; Zoso A; Milan G; Macino B; Dalla Santa S; Tosello V; Di Carlo E; Musiani P; Whalen RG; Zanovello P
    J Immunol; 2003 Nov; 171(10):5172-9. PubMed ID: 14607917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the p815 murine tumor.
    Levraud JP; Pannetier C; Langlade-Demoyen P; Brichard V; Kourilsky P
    J Exp Med; 1996 Feb; 183(2):439-49. PubMed ID: 8627157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A.
    Markiewicz MA; Fallarino F; Ashikari A; Gajewski TF
    Int Immunol; 2001 May; 13(5):625-32. PubMed ID: 11312250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A.
    Warnier G; Duffour MT; Uyttenhove C; Gajewski TF; Lurquin C; Haddada H; Perricaudet M; Boon T
    Int J Cancer; 1996 Jul; 67(2):303-10. PubMed ID: 8760603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL.
    Silla S; Fallarino F; Boon T; Uyttenhove C
    Eur Cytokine Netw; 1999 Jun; 10(2):181-90. PubMed ID: 10400824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
    Van den Eynde B; Lethé B; Van Pel A; De Plaen E; Boon T
    J Exp Med; 1991 Jun; 173(6):1373-84. PubMed ID: 1903428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca
    Frick M; Mouchacca P; Verdeil G; Hamon Y; Billaudeau C; Buferne M; Fallet M; Auphan-Anezin N; Schmitt-Verhulst AM; Boyer C
    Immunology; 2017 Feb; 150(2):199-212. PubMed ID: 27716898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
    Van den Eynde B; Peeters O; De Backer O; Gaugler B; Lucas S; Boon T
    J Exp Med; 1995 Sep; 182(3):689-98. PubMed ID: 7544395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of the tumor-specific P1A gene product.
    Amar-Costesec A; Godelaine D; Van den Eynde B; Beaufay H
    Biol Cell; 1994; 81(3):195-203. PubMed ID: 7696973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.
    Näslund TI; Uyttenhove C; Nordström EK; Colau D; Warnier G; Jondal M; Van den Eynde BJ; Liljeström P
    J Immunol; 2007 Jun; 178(11):6761-9. PubMed ID: 17513723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth.
    Vandermeulen G; Uyttenhove C; De Plaen E; Van den Eynde BJ; Préat V
    Bioelectrochemistry; 2014 Dec; 100():112-8. PubMed ID: 24342164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
    Brichard VG; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
    Eur J Immunol; 1995 Mar; 25(3):664-71. PubMed ID: 7705394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.